DR info

Clinical trials : 4 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 44

Drugs and their primary sponsors and trial info

ACZ885
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;
ACZ885D
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Canakinumab
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Ilaris
   Novartis pharma AG
      -   Phase 3   EUCTR2017-001678-40-Outside-EU/EEA   Japan;
Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;